Search Within

Ellen Arielle Ronnen

Formats
  1. Journal Article (5)
  2. Meeting Abstract (4)
  3. Book Section (1)
  4. Book Whole (1)
Groups
  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (11)
  3. Genitourinary Oncology Service (10)
  4. Body Imaging Service (6)
  5. Radiology, Department of (6)
  6. Nursing (5)

More Groups

People
  1. Robert Motzer (10)
  2. Gnanamba Kondagunta (7)
  3. Michelle Ginsberg (5)
  4. Nicole Leoce (5)
  5. Jennifer Bacik (4)
  6. Michael Baum (4)

More People

Years
  1. 2009 (1)
  2. 2008 (2)
  3. 2007 (1)
  4. 2006 (4)
  5. 2005 (3)
Publications
  1. Journal of Clinical Oncology (6)
  2. Cancer (1)
  3. Clinical Management of Renal Tumors (1)
  4. Hematology and oncology pearls (1)
  5. Investigational New Drugs (1)
  6. Urology (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. Elsevier Science, Inc. (1)
  3. Humana Press Inc (1)
  4. Mosby Elsevier (1)
  5. Springer (1)
  6. Wiley Blackwell (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Feldman, D. R.; Baum, M. S.; Ginsberg, M. S.; Hassoun, H.; Flombaum, C. D.; Velasco, S.; Fischer, P.; Ronnen, E.; Ishill, N.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I trial of bevacizumab plus sunitinib in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Feldman, D. R.; Ginsberg, M. S.; Baum, M.; Flombaum, C.; Hassoun, H.; Velasco, S.; Fischer, P.; Ishill, N. M.; Ronnen, E. A.; Motzer, R. J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Signal transduction inhibitors in renal cell carcinoma
    Book Section

    Ronnen, E. A.; George, S.; Bukowski, R. M.; Motzer, R. J.
    In Bukowski, R. M.; Novick, A. C. (Eds.) Clinical Management of Renal Tumors (2008)

    Fulltext@MSK | Save
  • Phase I trial of bevacizumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Feldman, D. R.; Kondagunta, G. V.; Ronnen, E. A.; Fischer, P.; Chang, R.; Baum, M.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase I study of sunitinib malate (SU11248) in combination with gefitinib in patients with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Ronnen, E. A.; Kondagunta, G. V.; Lau, C.; Fischer, P.; Ginsberg, M. S.; Baum, M.; Kim, S. T.; Chen, I.; Baum, C. M.; Motzer, R. J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma
    Journal Article

    Ronnen, E. A.; Kondagunta, G. V.; Ishill, N.; Sweeney, S. M.; DeLuca, J. K.; Schwartz, L.; Bacik, J.; Motzer, R. J.
    Investigational New Drugs (2006)

    Fulltext@MSK | Save
  • Treatment outcome for metastatic papillary renal cell carcinoma patients
    Journal Article

    Ronnen, E. A.; Kondagunta, G. V.; Ishill, N.; Spodek, L.; Russo, P.; Reuter, V.; Bacik, J.; Motzer, R. J.
    Cancer (2006)

    Fulltext@MSK | Save
  • Long-term response with sunitinib for metastatic renal cell carcinoma
    Journal Article

    Ronnen, E. A.; Kondagunta, G. V.; Ginsberg, M. S.; Russo, P.; Motzer, R. J.
    Urology (2006)

    Fulltext@MSK | Save
  • Hematology and oncology pearls
    Book Whole


    Mosby Elsevier (2005)

    Fulltext@MSK | Save
  • Treatment outcome and incidence for late relapse of germ cell tumor (GCT) patients (pts): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Ronnen, E. A.; Kondagunta, G. V.; Bacik, J.; Marion, S.; Bajorin, D. F.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save